Canadian Markets close in 3 hrs 21 mins

Genomic Health, Inc. (GHDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
33.35+0.08 (+0.24%)
As of 12:38PM EDT. Market open.
People also watch
Full screen
Previous Close33.27
Bid33.30 x 100
Ask33.44 x 100
Day's Range32.99 - 33.52
52 Week Range25.66 - 33.97
Avg. Volume115,771
Market Cap1.15B
PE Ratio (TTM)-132.87
EPS (TTM)-0.25
Earnings DateAug 1, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est31.70
Trade prices are not sourced from all markets
  • PR Newswire5 hours ago

    Genomic Health to Announce Second Quarter 2017 Financial Results and Host Conference Call on Tuesday, August 1, 2017

    REDWOOD CITY, Calif. , July 20, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Tuesday, August 1 at 4:30 p.m. Eastern ...

  • PR Newswire8 days ago

    Updated St. Gallen International Breast Cancer Guidelines Reinforce Important Role of Genomic Testing in Treatment of Early Breast Cancer

    REDWOOD CITY, Calif., July 12, 2017 /PRNewswire/ -- Genomic Health, Inc. (GHDX) today announced that the 15th St. Gallen International Breast Cancer Conference Expert Panel endorsed the use of genomic tests in early-stage breast cancer and recognized the Oncotype DX Breast Recurrence Score® test for its prognostic ability as well as its value in guiding treatment decisions on adjuvant chemotherapy for patients with early-stage, endocrine-sensitive, invasive breast cancer. In particular, Oncotype DX® was the only test supported by a majority of panelists (58.6 percent) for its value in providing information that can help physicians "decide to omit chemotherapy" in patients with node-positive disease (up to three nodes).

  • Capital Cube21 days ago

    ETFs with exposure to Genomic Health, Inc. : June 29, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Genomic Health, Inc. Here are 5 ETFs with the largest exposure to GHDX-US. Comparing the performance and risk of Genomic Health, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)